Press Releases

 Filter by Provider

General Mills, Inc. (NYSE: GIS) plans to report results for its fiscal 2027 first quarter on September 23, 2026.

Sovereign Agentic AI solution automates aircraft maintenance lifecycles, drives operational efficiencies, and sets new benchmark for heavy asset tracking

Manish Bhatia appointed President and Chief Operating Officer; Scott DeBoer appointed President and Chief Technology and Products Officer 

Collaboration pairs Securitize’s regulated tokenization infrastructure with CURRENC Capital’s first-hand issuer experience to help listed companies evaluate regulated approaches to bringing public-company shares onchain

New production-ready experience puts AFP news content within Dalet Flex, offering rich editorial intelligence that lays the foundation for trusted AI-assisted production workflows.

Former Kinaxis and OpenText product leader joins to converge network data, enterprise platforms, and intelligence across TrueCommerce’s global supply chain network

Available now in the AssetMark Advisor Portal, the new capability turns portfolio data and market context into personalized talking points and marks the latest in a broader pipeline of AI-enabled innovations

BOSTON, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Odyssey Therapeutics, Inc. (Nasdaq: ODTX) (“Odyssey” or the “Company”), a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that precisely target disease pathology, today announced that members of its management team will participate in the following upcoming investor conferences in September:

LISLE, Ill., Aug. 26, 2026 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE: CTS) today announced that its portfolio of current sensing solutions is now available through its network of authorized distribution partners, broadening access for customers across a wide range of high-growth, non-automotive markets.

NAARDEN, The Netherlands and MIAMI, Aug. 26, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that it will present data from its obicetrapib development program at the European Society of Cardiology (ESC) Congress 2026, taking place August 28 – 31, 2026 in Munich, Germany.

First comprehensive presentation of Rezolve Ai’s expanded strategy will connect trusted data, proprietary AI, auditable agent orchestration, commerce and payments following Google’s selection of the Company’s distributed database platform

Fifth Third Bancorp (NYSE: FITB) today announced the dual listing of its common stock on NYSE Texas in Dallas. Fifth Third will maintain its primary listing on the New York Stock Exchange and will trade on NYSE Texas under the same “FITB” ticker symbol, effective August 27, 2026.

New Nebraska biotechnology program and scholarship build on education and workforce partnerships across Novonesis’ U.S. communities

DENVER, Aug. 26, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2026 fiscal fourth quarter and full year financial results on Tuesday, September 8, 2026, after market close. In conjunction, the Company will host a conference call to review the results at 5 p.m. E.T.

Expansion means clients no longer need to live near a Guidelight clinic to access the same structured, skills-based care

The company extends its Inc. 5000 streak to 15 consecutive years, reflecting sustained growth driven by its team, partners, and more than 860,000 USCCA Members.

Initial phase study marks the clinical evaluation of the Abreu BTT 700 TMS and its thermofebrile protocol, laying the foundation for future efficacy trials in the treatment of ALS and other neurodegenerative disorders 

CHANTILLY, Va., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Associa, the industry’s largest community management company, announced the promotion of Jaime Valentine, CMCA, AMS, to vice president, branch administration for Community Management Corporation and Select Community Services. CMC-SCS is an Associa company serving communities throughout the Washington, D.C. metropolitan area. 

National nine-city education series expands Hydrafacial's industry-leading provider training platform

POMPANO BEACH, Fla., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Curonix LLC, a leading medical technology company dedicated to relieving chronic pain, today announced the appointment of Carlos A. Migoya to its Board of Managers, effective immediately.Migoya brings extensive leadership experience spanning healthcare administration, financial services, and public sector management. He has a distinguished record of leading complex organizations, directing strategic growth initiatives, and fostering operational excellence across healthcare and financial institutions. Drawing on this experience, he will help guide Curonix's strategic initiatives as the company broadens its impact in chronic pain management and patient care.“The addition of Carlos to our Board marks an important step as we continue to build a world-class leadership team dedicated to advancing innovation in chronic pain care," said Aure Bruneau, Chief Executive Officer of Curonix. “Carlos has built an exceptional career leading large, complex organizations across healthcare, government, and financial services. His knowledge in strategic planning, organizational leadership, and financial management will be important as we continue extending the reach of the Freedom® PNS System and advancing our strategic growth in chronic pain care."Migoya most recently served as President and Chief Executive Officer of Jackson Health System, one of the nation’s largest public healthcare networks, where he led organizational and operational initiatives that strengthened patient care and academic medicine. He previously served as City Manager for the City of Miami and in senior leadership roles at Wells Fargo, Wachovia, and their predecessor organizations. He has also served on the boards of publicly traded companies, including Mednax, Inc. (now Pediatrix Medical Group, Inc.), and remains actively involved in numerous civic, healthcare, and community organizations."It’s a privilege to join the Curonix Board and contribute to the company’s continued growth and future success," said Carlos Migoya. "Curonix is advancing innovative, non-opioid solutions that are designed to help patients suffering from chronic pain. I look forward to working alongside the Board and leadership team to support the company's focused growth, expand access to its technology, and help shape the future of chronic pain care."

NEW YORK, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hub Group, Inc. (“Hub Group” or the “Company”) (NASDAQ: HUBG) on behalf of investors that purchased or otherwise acquired Hub Group securities between April 28, 2023 and May 11, 2026 (the “Class Period”).

Nationwide network of Integer’s university-based applied research facilities advances defense research and accelerates maritime technology transition for the DOW

Nebius Group N.V. (the “Company”; Nasdaq: NBIS), the AI cloud company, today announced that all resolutions proposed at the Annual General Meeting of the Company (the “AGM”), held on August 25, 2026, have been adopted.

Trace3 announced its intent to complete a carve-out acquisition of Calian Group’s (TSX:CGY) U.S. Commercial IT business, expanding Trace3’s national footprint and strengthening its managed services capabilities for enterprise clients.

Toronto, Ontario--(Newsfile Corp. - August 26, 2026) - Tenet Fintech Group Inc. (CSE: PKK) (OTC Pink: PKKFF) ("Tenet" or the...

The corrected official transcripts are now public. FDA's supervising scientist named who directed the change in standard: the Assistant Secretary for Health - the same office that produced the government's headline evidence and never sent a witness.

Stuart Therapeutics, Inc. (“Stuart”), a late-stage biopharmaceutical company developing first-in-class collagen-reparative therapeutics to treat eye diseases, today announced the appointment of Dave LeCause as senior commercial advisor. LeCause will lead the company's commercial strategy as Stuart advances its lead therapeutic candidate, ST-100 for dry eye disease. ST-100 is expected to begin Phase 3b clinical trials in the first quarter of 2027.

Nestimate, the innovative investment due diligence platform, has announced that its Target-Date Fund IQ Analysis tool is now available through PGIM, giving retirement plan advisors access to an objective framework for evaluating target-date funds and lifetime income solutions.

VANCOUVER, BC / ACCESS Newswire / August 26, 2026 / Influential Women media brand (influentialwomen.com) which known for its digital magazine, long-form podcast, and executive network-has emerged as a central space for female leaders across business, marketing, tech, and healthcare.

Hong Kong, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Cre8 Enterprise Limited (Nasdaq: CRE) (“Cre8” or the “Company”), a Hong Kong-based integrated financial printing service provider, announced today that the number of customers it served and its project backlog each reached record levels as of June 30, 2026, primarily driven by a surge in regional capital markets activity.

ROCHESTER, NEW YORK, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (Nasdaq: OPTX), a leading provider of deep tech for the defense, space, AI data centers, and other vibrant end-markets, today announced a new order to build specialized high-tech waveguides for space satellites. After working on it for the past six months, Syntec is now ramping up to build and ship the product every week. 

HIGHLIGHTS

You spend roughly one third of your life in bed. That is more time than you spend in any other single room. Yet most people think more about the air quality in their living room or kitchen than they do about the air they breathe for eight hours straight while…

Better Mortgage (NASDAQ: BETR) and Coinbase (NASDAQ: COIN) today announced general availability for Better’s token-backed, conforming mortgage product. These first-of-its-kind mortgages will be originated and serviced by Better, powered by Coinbase, and designed in accordance with guidelines from Fannie Mae, making the first lien a standard, conforming mortgage.

APi Group Corporation (NYSE: APG) (“APi” or the “Company”) today announced that its senior leadership team will be participating in a fireside chat at the 2026 Jefferies Global Industrials Conference on Wednesday, September 9 at 9:30 a.m. ET.

Most women spend months, sometimes years, unsure about what they’re experiencing before they ever mention perimenopause to a doctor. A new survey from ThisIsMenopause of 1,000 U.S. women ages 35 to 59 finds that 82% initially attributed their first perimenopause symptoms to something else entirely, most often anxiety, burnout, or everyday stress. Only 14% recognized right away that they were experiencing perimenopause symptoms and 16% took longer than a year, some more than two.

QumulusAI (Nasdaq: QMLS), a neocloud infrastructure provider purpose-built for the AI computing era, today announced an amendment to the surface lease at its Oklahoma data center, extending the company’s potential tenure at the site through January 31, 2044.

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced details for a dedicated Program Overview webinar for XP-8121, the Company’s Phase 3-ready, once-weekly subcutaneous levothyroxine injection in development for the treatment of hypothyroidism.

- The ASCEND-ATTR study builds on the Phase 3 ATTRibute-CM CMR substudy results previously shared here, which indicated treatment with acoramidis may improve cardiac structure and function with evidence of amyloid regression in a subset of patients

MILLBRAE, Calif., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical needs, today announced that Roger M. Perlmutter, M.D., Ph.D., Chairman and Chief Executive Officer, and Freddie Bowie, Ph.D., Chief Financial Officer, will participate in two upcoming investor conferences taking place in September:

NEW ALBANY, Ohio, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Abercrombie & Fitch Co. (NYSE: ANF) today announced results for the second quarter ended August 1, 2026. These compare to results for the second quarter ended August 2, 2025. Descriptions of the use of non-GAAP financial measures and reconciliations of GAAP and non-GAAP financial measures accompany this release.

GSilver reports Q2 operating income of US$9.1M

CHIP reports five sites across North America, 20 MW committed to a global off-taker

With the global data center market projected to grow from approximately US$300 billion in 2026 to about US$700 billion by 2034, maintaining fuel integrity is becoming an increasingly important operational priority

Toronto, Ontario, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Fort Technology Inc. (Nasdaq: FRTT, TSXV: FORT) (“Fort” or the “Company”), today announced that on August 26, 2026, it has completed its previously announced acquisition of 50.1% of Logia USA Inc. (“Logia USA”), a company focused on selling advanced fuel integrity solutions for data centers and other mission-critical facilities in the United States. Further to the equity rebalancing mechanism as described in the Company’s press release issued on August 11, 2026, the Company’s shareholding in Logia USA may be decreased to 5% upon the achievement of certain sale milestones by Logia USA. On closing, the Company issued an aggregate of 132,603 common shares (US$125,000) in the capital of Company to Mr. Yair Harel, the founder of Logia USA. The transaction is arm’s length and no finder’s fee is payable.

OTTAWA, Ontario, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Calian Group Ltd. (“the Company”) (TSX: CGY), a mission-critical solutions company focused on defence, space, healthcare and other critical infrastructure sectors, today announced it has entered into a definitive agreement to sell its United States (U.S.) commercial IT business based in Houston, Texas, to Trace3, a leading technology solutions provider and digital transformation consultancy headquartered in Irvine, California.

Calgary, Alberta--(Newsfile Corp. - August 26, 2026) - Legacy Gold Mines Ltd. (TSXV: LEGY) (the "Company" or "Legacy Gold") is...

New Professional Women's Volleyball Franchise to Celebrate Its Los Angeles Arrival With Brand Launch, Select-a-Seat Experience and Fan Fest

System Sales Up nearly 12% and Fleet Adjusted EBITDA Up 45% in the Second Quarter; Working Capital Returns to Positive Following the Close of its Q2 Oversubscribed $5.1M Private Placement